series-b
Stage
1
Investors
About
Kinaset Therapeutics develops inhaled anti-inflammatory therapeutics targeting respiratory diseases, including severe asthma, delivering drugs directly to the lungs to minimize systemic exposure.
Explore Kinaset Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.